Cromwell, Conn. — A wholly owned subsidiary of Royal DSM, i-Health Inc., has revealed that it has entered into a purchase agreement towards obtaining UP4 Probiotic Brand from UAS Laboratories. A specialty channel brand, UP4 features a variety of options in its full line of probiotic products, while iHealth is a global science based company focused on health and nutrition. There has been no disclosure as to the terms of the deal.
“The acquisition of the successful, fast growing and scientifically supported UP4 brand of probiotics will expand and accelerate i-Health’s leadership position in the probiotic category,” stated Wes Parris, i-Health’s CEO. “I am excited about the prospect of delivering even more new growth platforms based on strong science and innovation into the fast growing probiotic category. In addition, the UP4 brand represents a perfect strategic complement to our category leading brand Culturelle.”
UP4 will join i-Health’s current leading women’s health brand Estroven and AZO.
“I am thankful and proud of the talented and passionate team at UAS Labs that built UP4 Probiotics into a compelling brand that resonates with today’s consumers,” added Kevin Mehring, UAS Labs CEO. “Their efforts helped expand the brand in health food stores plus gain distribution in Target, grocery and specialty supplement stores nationwide. We know the experienced team at i-Health, will build upon this growth and take the UP4 brand to the next level ultimately helping more consumers live a healthier life with our probiotic based solutions.”